Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

The Donut Hole Dilemma: Retaining Lost Patients Under Medicare Part D

This article was originally published in RPM Report

Executive Summary

Finally, some statistics about the impact of the Medicare Part D donut hole. The good news: drug manufacturers need not worry about most patients entering the coverage gap. The bad: a relatively large number of the industry's best customers do reduce their medication use in the donut hole-and if a customer is lost to the donut hole, they may be lost for good.

You may also be interested in...



Putting the Dough in the Donut Hole: Big Pharma Hits the Sweet Spot in the Reform Debate

It's not often than any industry group voluntarily agrees to give up $80 billion in future revenues, but that's what the Pharmaceutical Research & Manufacturers of America is pledging to do to in the context of the health care reform debate. There are a lot of details to work out, but this is a case where what is important is not what PhRMA is giving-but what it gets.

Dollars for Donuts: Inside the Key Elements of PhRMA's Health Reform Deal

The key part of PhRMA's deal with the Finance Committee is a double win for industry: assuring that closing the donut hole will be part of reform, and that PhRMA will get credit for a big part of the savings.

Going Bust in Part D: Sierra Folds to United

Playing for high stakes is fun, but not if you find yourself matched against bigger players who are holding all the cards. That must by how Sierra Health Systems feels after being cleaned out by the two Medicare goliaths, Humana and UnitedHealth Group.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

PS080483

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel